Melissa Moore

Effects of a wearable technology-based physical activity intervention on sleep quality in breast cancer survivors: the ACTIVATE Trial

Nga H Nguyen, Jeff K Vallance, Matthew P Buman, Melissa M Moore, Marina M Reeves, Dori E Rosenberg, Terry Boyle, Shakira Milton, Christine M Friedenreich, Dallas R English, Brigid M Lynch

Journal article  |  2020  |  JOURNAL OF CANCER SURVIVORSHIP

INTRODUCTION: Physical activity interventions can improve sleep quality in breast cancer survivors. This paper examines the effect..

Effects of the ACTIVity And TEchnology (ACTIVATE) intervention on health-related quality of life and fatigue outcomes in breast cancer survivors

Jeff K Vallance, Nga H Nguyen, Melissa M Moore, Marina M Reeves, Dori E Rosenberg, Terry Boyle, Shakira Milton, Christine M Friedenreich, Dallas R English, Brigid M Lynch

Journal article  |  2019  |  PSYCHO-ONCOLOGY

BACKGROUND: The ACTIVATE Trial examined the efficacy of a wearable-based intervention to increase physical activity and reduce sed..

A randomized controlled trial of a wearable technology-based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial

Brigid M Lynch, Nga H Nguyen, Melissa M Moore, Marina M Reeves, Dori E Rosenberg, Terry Boyle, Jeff K Vallance, Shakira Milton, Christine M Friedenreich, Dallas R English

Journal article  |  2019  |  CANCER

BACKGROUND: The benefits of an active lifestyle after a breast cancer diagnosis are well recognized, but the majority of survivors..

Study design and methods for the ACTIVity And TEchnology (ACTIVATE) trial

Brigid M Lynch, Nga H Nguyen, Marina M Reeves, Melissa M Moore, Dori E Rosenberg, Michael J Wheeler, Terry Boyle, Jeff K Vallance, Christine M Friedenreich, Dallas R English

Journal article  |  2018  |  CONTEMPORARY CLINICAL TRIALS

BACKGROUND: Physical activity is positively associated with survival and quality of life among breast cancer survivors. Despite th..

A qualitative evaluation of breast cancer survivors' acceptance of and preferences for consumer wearable technology activity trackers

Nga H Nguyen, Nyssa T Hadgraft, Melissa M Moore, Dori E Rosenberg, Chris Lynch, Marina M Reeves, Brigid M Lynch

Journal article  |  2017  |  SUPPORTIVE CARE IN CANCER

BACKGROUND: Physical inactivity and sedentary behaviour are common amongst breast cancer survivors. These behaviours are associate..

EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma

Timothy D Clay, Prudence A Russell, Hongdo Do, Vijaya Sundararajan, Matthew Conron, Gavin M Wright, Benjamin Solomon, Alexander Dobrovic, Sue-Anne McLachlan, Melissa M Moore

Journal article  |  2017  |  MEDICAL ONCOLOGY

Resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) against EGFR mutant lung adenocarcinoma de..

P2.07-008 Victorian Comprehensive Cancer Centre Lung Cancer Clinical Audit: Collecting the UK National Lung Cancer Audit data from hospitals in Australia

Linda Mileshkin, Tamsin Waterhouse, Hannah Cross, Mary Duffy, Paula Nelson, Mark Shaw, Paul Mitchell, Tim Akhurst, Louis Irving, Matthew Conron, Melissa Moore, Jennifer Philip, Stephen Barnett, Philip Antippa, James Bartlett, Jon Emery, Jennifer Byrne, Jim Bishop

Conference Proceedings  |  2017  |  Journal of Thoracic Oncology

Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations

TD Clay, PA Russell, H Do, V Sundararajan, M Conron, GM Wright, A Dobrovic, MM Moore, SA McLachlan

Journal article  |  2016  |  PATHOLOGY

We sought to investigate the frequency of mutations in epidermal growth factor receptor (EGFR) and Kirsten-RAS (KRAS) by each path..

The Clinical Relevance of Pathologic Subtypes in Metastatic Lung Adenocarcinoma

Timothy D Clay, Hongdo Do, Vijaya Sundararajan, Melissa M Moore, Matthew Conron, Gavin M Wright, Sue-Anne McLachlan, Alexander Dobrovic, Prudence A Russell

Journal article  |  2014  |  JOURNAL OF THORACIC ONCOLOGY

INTRODUCTION: The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society cl..

EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinoma

Prudence A Russell, Yong Yu, Hongdo Do, Timothy D Clay, Melissa M Moore, Gavin M Wright, Matthew Conron, Zoe Wainer, Alexander Dobrovic, Sue-Anne McLachlan

Journal article  |  2014  |  PATHOLOGY

We investigated if gene copy number (GCN) alterations of the epidermal growth factor receptor (EGFR), as detected by silver enhanc..